1. Home
  2. UGRO vs EVAX Comparison

UGRO vs EVAX Comparison

Compare UGRO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • EVAX
  • Stock Information
  • Founded
  • UGRO 2014
  • EVAX 2008
  • Country
  • UGRO United States
  • EVAX Denmark
  • Employees
  • UGRO N/A
  • EVAX N/A
  • Industry
  • UGRO Industrial Specialties
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UGRO Consumer Discretionary
  • EVAX Health Care
  • Exchange
  • UGRO Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • UGRO 8.8M
  • EVAX 8.7M
  • IPO Year
  • UGRO N/A
  • EVAX 2021
  • Fundamental
  • Price
  • UGRO $0.76
  • EVAX $2.61
  • Analyst Decision
  • UGRO Strong Buy
  • EVAX Strong Buy
  • Analyst Count
  • UGRO 2
  • EVAX 3
  • Target Price
  • UGRO $5.63
  • EVAX $33.33
  • AVG Volume (30 Days)
  • UGRO 133.0K
  • EVAX 6.9M
  • Earning Date
  • UGRO 03-26-2025
  • EVAX 03-26-2025
  • Dividend Yield
  • UGRO N/A
  • EVAX N/A
  • EPS Growth
  • UGRO N/A
  • EVAX N/A
  • EPS
  • UGRO N/A
  • EVAX N/A
  • Revenue
  • UGRO $70,320,066.00
  • EVAX $3,295,000.00
  • Revenue This Year
  • UGRO $17.15
  • EVAX $9,039.73
  • Revenue Next Year
  • UGRO $21.76
  • EVAX $1.47
  • P/E Ratio
  • UGRO N/A
  • EVAX N/A
  • Revenue Growth
  • UGRO 12.08
  • EVAX N/A
  • 52 Week Low
  • UGRO $0.60
  • EVAX $2.22
  • 52 Week High
  • UGRO $2.84
  • EVAX $22.50
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 38.85
  • EVAX 40.78
  • Support Level
  • UGRO $0.66
  • EVAX $2.30
  • Resistance Level
  • UGRO $1.12
  • EVAX $2.90
  • Average True Range (ATR)
  • UGRO 0.12
  • EVAX 0.64
  • MACD
  • UGRO 0.01
  • EVAX 0.03
  • Stochastic Oscillator
  • UGRO 30.25
  • EVAX 7.29

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

Share on Social Networks: